Bryan V Lawlis

Affiliations

  • Director at Geron Corp (GERN), 2025-05-22
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2023-05-24
  • Director at Aeglea Biotherapeutics Inc. (AGLE), 2022-06-10
  • Director at Coherus Biosciences Inc. (CHRS), 2021-01-13
  • Director at Sutro Biopharma Inc (STRO), 2018-09-27
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2014-06-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GERN $1.18 13,300 $15,667.40 13,300 2025-05-09 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GERN $3.75 35,000 $131,250.00 0 2024-05-15 Filing
GERN $3.00 35,000 $105,000.00 0 2023-05-11 Filing
BMRN $97.09 8,500 $825,265.00 28,950 2023-04-03 Filing
BMRN $83.66 4,250 $355,555.00 23,970 2022-04-14 Filing
BMRN $87.61 4,250 $372,342.50 23,970 2022-01-14 Filing